Skip to Main Content

Paper Details

Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs?
JAMA Oncol
0
2023
Author NameAffiliation
Mark J RatainUniversity of Chicago
  • 1 - 1

Datasets

Release 1.2